MANAGEMENT OF ENDOCRINE DISEASE: Management of pregnant patients with Cushing's syndrome

European Journal of Endocrinology

Volumn 173, Issue 2, 2015, Pages R85-R91

  Bronstein, M D ^a   Machado, M C ^a   Fragoso, M C B V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; CABERGOLINE; KETOCONAZOLE; METYRAPONE; MITOTANE;

ADRENAL INSUFFICIENCY; ADRENALECTOMY; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DISEASE ASSOCIATION; DRUG RESPONSE; DRUG SAFETY; ECHOGRAPHY; GESTATIONAL AGE; HORMONE DETERMINATION; HUMAN; HYPERCORTISOLISM; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; TERATOGENICITY; TRANSSPHENOIDAL SURGERY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; DISEASE MANAGEMENT; FEMALE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PREGNANCY COMPLICATIONS;

CUSHING SYNDROME; DISEASE MANAGEMENT; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84938837447     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-1130     Document Type: Review

References (34)

1. Lindsay JR & Nieman LK. The hypothalamic-pituitary-adrenal axis in pregnancy: challenges in disease detection and treatment. Endocrine Reviews 2005 26 775-799. (doi:10.1210/er.2004-0025)
2. Sehringer B, Zahradnik HP, Simon M, Ziegler R, Noethling C &Schaefer WR. mRNA expression profiles for corticotrophin-releasing hormone, urocortin, CRH-binding protein and CRH receptors in human term gestational tissues determined by real-time quantitative RT-PCR. Journal of Molecular Endocrinology 2004 32 339-348. (doi:10.1677/jme.0.0320339)
3. Wetzka B, Sehringer B, Schafer WR, Biller S, Hör C, Benedek E, Deppert WR & Zahradnik HP. Expression patterns of CRH, CRH receptors, and CRH binding protein in human gestational tissue at term. Experimental and Clinical Endocrinology & Diabetes 2003 111 154-161. (doi:10.1055/s-2003-39778)
4. Carr BP, Parker CR Jr, Madden JD, MacDonald PC & Porter JC. Maternal plasma adrenocorticotropin and cortisol relationships throughout human pregnacy. American Journal of Obstetrics and Gynecology 1981 139 416-422.
5. Behan DP, Linton EA & Lowry PJ. Isolation of the human plasma corticotrophin-releasing factor-binding protein. Journal of Endocrinology 1989 122 23-31. (doi:10.1677/joe.0.1220023)
6. Demey-Ponsart E, Foidart JM, Sulon J & Sodoyez JC. Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy. Journal of Steroid Biochemistry 1982 16 165-169. (doi:10.1016/0022-4731(82)90163-7)
7. Nolten WE, Lindheimer MD, Rueckert PA, Oparil S & Ehrlich EN. Diurnal patterns and regulation of cortisol secretion in pregnancy. Journal of Clinical Endocrinology and Metabolism 1980 51 466-472. (doi:10.1210/jcem-51-3-466)
8. Jung C, Ho JT, Torpy DJ, Rogers A, Doogue M, Lewis JG, Czajko RJ &Inder WJ. A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum. Journal of Clinical Endocrinology and Metabolism 2011 96 1533-1540. (doi:10.1210/jc.2010-2395)
9. Odagiri E, Ishiwatari N, Abe Y, Jibiki K, Adachi T, Demura R, Demura H & Shizume K. Hypercortisolism and the resistance to dexamethasone suppression during gestation. Endocrinologia Japonica 1988 35 685-690. (doi:10.1507/endocrj1954.35.685)
10. Schulte HM, Weisner D & Allolio B. The corticotrophin releasing hormone test in late pregnancy: lack of adrenocorticotrophin and cortisol response. Clinical Endocrinology 199033 99-106. (doi:10.1111/j.1365-2265.1990.tb00470.x)
11. Suda T, Iwashita M, Ushiyama T, Tozawa F, Sumitomo T, Nakagami Y, Demura H & Shizume K. Responses to corticotropin-releasing hormone and its bound and free forms in pregnant and nonpregnant women. Journal of Clinical Endocrinology and Metabolism 1989 69 38-42. (doi:10.1210/jcem-69-1-38)
12. Linton EA, Perkins AV, Woods RJ, Eben F, Wolfe CD, Behan DP, Potter E, Vale WW & Lowry PJ. Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy. Journal of Clinical Endocrinology and Metabolism 1993 76 260-262.
13. Pivonello R, De Martino MC, Auriemma RS, Alviggi C, Grasso LF, Cozzolino A, De Leo M, De Placido G, Colao A & Lombardi G. Pituitary tumors and pregnancy: the interplay between a pathologic condition and a physiologic status. Journal of Endocrinological Investigation 2014 37 99-112. (doi:10.1007/s40618-013-0019-8)
14. Prebtani AP, Donat D & Ezzat S. Worrisome striae in pregnancy. Lancet 2000 355 1692. (doi:10.1016/S0140-6736(00)02242-X)
15. Abdelmannan D & Aron DC. Adrenal disorders in pregnancy. Endocrinology and Metabolism Clinics of North America 2011 40 779-794. (doi:10.1016/j.ecl.2011.09.001)
16. McClamrock HD & Adashi EY. Gestational hyperandrogenism. Fertility and Sterility 1992 57 257-274.
17. Lindsay JR, Jonklaas J, Oldfield EH & Nieman LK. Cushing's syndrome during pregnancy: personal experience and review of the literature. Journal of Clinical Endocrinology and Metabolism 2005 90 3077-3083. (doi:10.1210/jc.2004-2361)
18. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2003 88 5593-5602. (doi:10.1210/jc.2003-030871)
19. Lacroix A, Ndiaye N, Tremblay J & Hamet P. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocrine Reviews 2001 22 75-110.
20. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM & Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1526-1540. (doi:10.1210/jc.2008-0125)
21. Pinette MG, Pan YQ, Oppenheim D, Pinette SG & Blackstone J. Bilateral inferior petrosal sinus corticotropin sampling with corticotropin-releasing hormone stimulation in a pregnant patient with Cushing's syndrome. American Journal of Obstetrics and Gynecology 1994 171 563-564. (doi:10.1016/0002-9378(94)90303-4)
22. Cabezon C, Bruno OD, Cohen M, Garcia S & Gutman RA. Twin pregnancy in a patient with Cushing's disease. Fertility and Sterility 1999 72 371-372. (doi:10.1016/S0015-0282(99)00261-7)
23. Vilar L, Freitas Mda C, Lima LH, Lyra R & Kater CE. Cushing's syndrome in pregnancy: an overview. Arquivos Brasileiros de Endocrinologia e Metabologia 2007 51 1293-1302.
24. Bronstein MD, Paraiba DB & Jallad RS. Management of pituitary tumors in pregnancy. Nature Reviews. Endocrinology 2011 7 301-310. (doi:10.1038/nrendo.2011.38)
25. Leiba S, Weinstein R, Shindel B, Lapidot M, Stern E, Levavi H, Rusecki Y & Abramovici A. The protracted effect of o,p′ -DDD in Cushing's disease and its impact on adrenal morphogenesis of young human embryo. Annales d'Endocrinologie 1989 50 49-53.
26. Lim WH, Torpy DJ & Jeffries WS. The medical management of Cushing's syndrome during pregnancy. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2013 168 1-6. (doi:10.1016/j.ejogrb.2012.12.015)
27. Blanco C, Maqueda E, Rubio JA & Rodriguez A. Cushing's syndrome during pregnancy secondary to adrenal adenoma: metyrapone treatment and laparoscopic adrenalectomy. Journal of Endocrinological Investigation 2006 29 164-167. (doi:10.1007/BF03344091)
28. Hana V, Dokoupilova M, Marek J & Plavka R. Recurrent ACTH-independent Cushing's syndrome in multiple pregnancies and its treatment with metyrapone. Clinical Endocrinology 2001 54 277-281. (doi:10.1046/j.1365-2265.2001.01055.x)
29. Connell JM, Cordiner J, Davies DL, Fraser R, Frier BM & McPherson SG. Pregnancy complicated by Cushing's syndrome: potential hazard of metyrapone therapy. Case report. British Journal of Obstetrics and Gynaecology 1985 92 1192-1195. (doi:10.1111/j.1471-0528.1985.tb03037.x)
30. Boronat M, Marrero D, Lopez-Plasencia Y, Barber M, Schamann Y &Novoa FJ. Successful outcome of pregnancy in a patient with Cushing's disease under treatment with ketoconazole during the first trimester of gestation. Gynecological Endocrinology 2011 27 675-677. (doi:10.3109/09513590.2010.521268)
31. Berwaerts J, Verhelst J, Mahler C & Abs R. Cushing's syndrome in pregnancy treated by ketoconazole: case report and review of the literature. Gynecological Endocrinology 1999 13 175-182. (doi:10.3109/09513599909167552)
32. Woo I & Ehsanipoor RM. Cabergoline therapy for Cushing disease throughout pregnancy. Obstetrics and Gynecology 2013 122 485-487. (doi:10.1097/AOG.0b013e31829e398a)
33. Achong N, D'Emden M, Fagermo N & Mortimer R. Pregnancy-induced Cushing's syndrome in recurrent pregnancies: case report and literature review. Australian & New Zealand Journal of Obstetrics & Gynaecology 2012 52 96-100. (doi:10.1111/j.1479-828X.2011.01388.x)
34. Mundra V, Solorzano C & DeSantis P. Cushing syndrome: a rare ocurrence in pregnancy. Endocrinologist 2010 20 165-167. (doi:10.1097/TEN.0b013e3181ecb06a)